The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology

The vast majority of acute heart failure episodes are characterized by increasing symptoms and signs of congestion with volume overload. The goal of therapy in those patients is the relief of congestion through achieving a state of euvolaemia, mainly through the use of diuretic therapy. The appropriate use of diuretics however remains challenging, especially when worsening renal function, diuretic resistance and electrolyte disturbances occur. This position paper focuses on the use of diuretics in heart failure with congestion. The manuscript addresses frequently encountered challenges, such as (i) evaluation of congestion and clinical euvolaemia, (ii) assessment of diuretic response/resistance in the treatment of acute heart failure, (iii) an approach towards stepped pharmacologic diuretic strategies, based upon diuretic response, and (iv) management of common electrolyte disturbances. Recommendations are made in line with available guidelines, evidence and expert opinion.

[1]  S. Morell,et al.  Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study. , 2016, JACC. Heart failure.

[2]  Jeffrey M. Turner,et al.  Loop Diuretic Efficiency: A Metric of Diuretic Responsiveness With Prognostic Importance in Acute Decompensated Heart Failure , 2014, Circulation. Heart failure.

[3]  W. Tang,et al.  Urinary Composition During Decongestive Treatment in Heart Failure With Reduced Ejection Fraction , 2014, Circulation. Heart failure.

[4]  D. Ellison,et al.  The WNK kinase network regulating sodium, potassium, and blood pressure. , 2011, Journal of the American Society of Nephrology : JASN.

[5]  G. Fonarow,et al.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.

[6]  Q. Swennen,et al.  The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’ , 2014, European journal of heart failure.

[7]  K. Damman,et al.  The kidney in heart failure: an update. , 2015, European heart journal.

[8]  W. Tang,et al.  Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. , 2014, Journal of cardiac failure.

[9]  M. Pfisterer,et al.  Use of B-type natriuretic peptide outside of the emergency department. , 2008, International journal of cardiology.

[10]  N. Benowitz,et al.  Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics , 1991, Cardiovascular Drugs and Therapy.

[11]  F. Wilson,et al.  An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial. , 2017, International journal of cardiology.

[12]  J. Waniewski,et al.  Kinetics of Plasma Refilling During Hemodialysis Sessions with Different Initial Fluid Status , 2015, ASAIO journal.

[13]  J. Massaro,et al.  Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. , 2017, Journal of the American College of Cardiology.

[14]  K. Tabei,et al.  A study on regulating factors of plasma refilling during hemodialysis. , 1996, Nephron.

[15]  P. Martens,et al.  Insights into implementation of sacubitril/valsartan into clinical practice , 2018, ESC heart failure.

[16]  V. Hasselblad,et al.  Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. , 2005, Journal of cardiac failure.

[17]  C. O'connor,et al.  Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From ASCEND-HF. , 2016, JACC. Heart failure.

[18]  M. Lainscak,et al.  Cardiac cachexia: hic et nunc: "hic et nunc" - here and now. , 2015, International journal of cardiology.

[19]  K. Anstrom,et al.  Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial , 2017, JAMA cardiology.

[20]  Brater Dc Pharmacokinetics of loop diuretics in congestive heart failure , 1994 .

[21]  C. Mathieu,et al.  Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond , 2017, Current Treatment Options in Cardiovascular Medicine.

[22]  K. White,et al.  Clinical epidemiology. , 1983, International journal of epidemiology.

[23]  G. Filippatos,et al.  Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. , 2016, Journal of the American College of Cardiology.

[24]  E. Mutschler,et al.  Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy , 1991, Klinische Wochenschrift.

[25]  Rui Placido,et al.  Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion , 2018, European journal of heart failure.

[26]  K. Mahaffey,et al.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.

[27]  H. Krumholz,et al.  Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives? , 2013, Journal of the American College of Cardiology.

[28]  K. Anstrom,et al.  Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). , 2015, Circulation. Heart failure.

[29]  W. Tang,et al.  Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome , 2019, Acta cardiologica.

[30]  M. Fischereder,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.

[31]  F. Wilson,et al.  Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure , 2016, Circulation. Heart failure.

[32]  F. Verbrugge,et al.  Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions. , 2017, The American journal of cardiology.

[33]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[34]  C. O'connor,et al.  Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury , 2018, Circulation.

[35]  A. Voors,et al.  Bio‐adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure , 2018, European journal of heart failure.

[36]  G. Volpicelli,et al.  Lung Ultrasound Predicts Well Extravascular Lung Water but Is of Limited Usefulness in the Prediction of Wedge Pressure , 2014, Anesthesiology.

[37]  A. Ducharme,et al.  Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. , 2006, American heart journal.

[38]  R. Matsukawa,et al.  Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.

[39]  J. Rouleau,et al.  Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure). , 2014, JACC. Heart failure.

[40]  K. Swedberg,et al.  Salt and fluid restriction is effective in patients with chronic heart failure , 2013, European journal of heart failure.

[41]  F. Sarullo,et al.  Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study) , 2011, The American journal of the medical sciences.

[42]  Nancy M Albert,et al.  HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.

[43]  X. Qian,et al.  Liberal versus restricted fluid administration in heart failure patients. A systematic review and meta-analysis of randomized trials. , 2015, International heart journal.

[44]  R. Agarwal,et al.  Thiazide diuretics in advanced chronic kidney disease. , 2012, Journal of the American Society of Hypertension : JASH.

[45]  A. Hoes,et al.  Clinical epidemiology of heart failure , 2007, Heart.

[46]  A. Odermatt,et al.  Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice. , 2013, Kidney international.

[47]  M. Vaduganathan,et al.  Water and Sodium in Heart Failure: A Spotlight on Congestion , 2014, Heart Failure Reviews.

[48]  W. Zoghbi,et al.  Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. , 1994, The American journal of cardiology.

[49]  G. Felker,et al.  Diuretics and ultrafiltration in acute decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[50]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[51]  W. Tang,et al.  The pathophysiological role of interstitial sodium in heart failure. , 2015, Journal of the American College of Cardiology.

[52]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[53]  C. Lindsell,et al.  Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. , 2006, Annals of emergency medicine.

[54]  K. Anstrom,et al.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.

[55]  P. Ponikowski,et al.  Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. , 2018, International journal of cardiology.

[56]  F. Zannad,et al.  Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality , 2016, Cardiorenal Medicine.

[57]  Y. Pinto,et al.  NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?) , 2018, Circulation.

[58]  M. Drazner,et al.  The Role of the Clinical Examination in Patients With Heart Failure. , 2018, JACC. Heart failure.

[59]  Andreas Schäfer,et al.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2017, European journal of heart failure.

[60]  Divya Gupta,et al.  Dietary Sodium Intake in Heart Failure , 2012, Circulation.

[61]  M. Drazner,et al.  Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per‐protocol analysis of CARRESS‐HF , 2018, European journal of heart failure.

[62]  W. Tang,et al.  Hyponatremia in acute decompensated heart failure: depletion versus dilution. , 2015, Journal of the American College of Cardiology.

[63]  W. Tang,et al.  Prognostic value of glomerular filtration changes versus natriuretic response in decompensated heart failure with reduced ejection. , 2014, Journal of cardiac failure.

[64]  J. McMurray,et al.  Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.

[65]  S. Barbic,et al.  Point-of-care ultrasonography for the diagnosis of acute cardiogenic pulmonary edema in patients presenting with acute dyspnea: a systematic review and meta-analysis. , 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[66]  Akshay S. Desai,et al.  Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. , 2016, JACC. Heart failure.

[67]  Jacob P. Kelly,et al.  Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). , 2017, The American journal of cardiology.

[68]  P. Ponikowski,et al.  Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine , 2010, European journal of heart failure.

[69]  G. Fonarow,et al.  Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure. , 2016, JACC. Heart failure.

[70]  F. Wilson,et al.  Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure , 2016, Circulation. Heart failure.

[71]  J. Soler‐Soler,et al.  Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction , 2005, European journal of heart failure.

[72]  J. McMurray,et al.  Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review , 2017, European journal of heart failure.

[73]  K. Swedberg,et al.  Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. , 2013, European heart journal.

[74]  P. Ponikowski,et al.  Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT‐CHF , 2017, European journal of heart failure.

[75]  Adrian F Hernandez,et al.  Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. , 2017, JACC. Heart failure.

[76]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[77]  Piotr Ponikowski,et al.  EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.

[78]  M. Drazner,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[79]  Adrian F. Hernandez,et al.  Combination of loop diuretics with thiazide-type diuretics in heart failure. , 2010, Journal of the American College of Cardiology.

[80]  R. Starling,et al.  Transient Hyponatremia During Hospitalization for Acute Heart Failure. , 2016, The American journal of medicine.

[81]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[82]  E. Mutschler,et al.  Sequential nephron blockade breaks resistance to diuretics in edematous states. , 1997, Journal of cardiovascular pharmacology.

[83]  F. Verbrugge,et al.  Value of routine investigations to predict loop diuretic down-titration success in stable heart failure. , 2018, International journal of cardiology.

[84]  S. McGee Physical examination of venous pressure: a critical review. , 1998, American heart journal.

[85]  D. Brater Pharmacokinetics of loop diuretics in congestive heart failure. , 1994, British heart journal.

[86]  G. Felker,et al.  Diuretic Treatment in Heart Failure. , 2017, The New England journal of medicine.

[87]  G. Filippatos,et al.  Renal dysfunction and heart failure: things are seldom what they seem. , 2014, European heart journal.

[88]  W. Tang,et al.  Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low , 2018, Acta cardiologica.

[89]  M. Isobe,et al.  Progression of hyponatremia is associated with increased cardiac mortality in patients hospitalized for acute decompensated heart failure. , 2012, Journal of cardiac failure.

[90]  M. Gheorghiade,et al.  Moving away from symptoms‐based heart failure treatment: misperceptions and real risks for patients with heart failure , 2016, European journal of heart failure.

[91]  William T. Abraham,et al.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .

[92]  M. Gheorghiade,et al.  Acute heart failure syndromes , 2009, Journal of the American College of Cardiology.

[93]  D. Ellison Diuretic Therapy and Resistance in Congestive Heart Failure , 2002, Cardiology.

[94]  Manesh R. Patel,et al.  Splanchnic Nerve Block for Acute Heart Failure. , 2018, Circulation.

[95]  G. Filippatos,et al.  Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial , 2018, European journal of heart failure.

[96]  P. Ponikowski,et al.  Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure , 2016, Circulation. Heart failure.

[97]  M. Zile,et al.  Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. , 2016, Journal of cardiac failure.

[98]  Akshay S. Desai,et al.  Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. , 2018, Journal of cardiac failure.

[99]  S. Houser,et al.  Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis , 2018, Journal of the American Heart Association.

[100]  G. Fonarow,et al.  Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure , 2017, Journal of the American College of Cardiology.

[101]  G. Filippatos,et al.  Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.

[102]  F. Verbrugge,et al.  Abdominal contributions to cardiorenal dysfunction in congestive heart failure. , 2013, Journal of the American College of Cardiology.

[103]  P. Vandervoort,et al.  Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload , 2015, Acta cardiologica.

[104]  R. Wenzel Diuretics in heart failure. , 1986, Lancet.

[105]  A. Cohen-Solal,et al.  Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. , 2015, International journal of cardiology.

[106]  K. Rentsch,et al.  Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function , 2017, European journal of heart failure.

[107]  Akshay S. Desai,et al.  Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring. , 2016, JACC. Heart failure.

[108]  G. Filippatos,et al.  Haemoconcentration, renal function, and post‐discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial , 2013, European journal of heart failure.

[109]  B. Zinman,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.

[110]  G. Alunni,et al.  Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure , 2015, European journal of heart failure.

[111]  S. Kimmel,et al.  Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.

[112]  K. Swedberg,et al.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.

[113]  S. Bachmann,et al.  Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. , 1985, The American journal of physiology.

[114]  J. Nanas,et al.  Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study. , 2014, International journal of cardiology.

[115]  R. Starling,et al.  Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[116]  W. Tang,et al.  Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment. , 2015, The American journal of medicine.

[117]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[118]  G. Filippatos,et al.  Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction , 2009, Clinical Research in Cardiology.

[119]  J. McMurray,et al.  Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction , 2016, European journal of heart failure.

[120]  M. Metra,et al.  Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?: The Role of Congestion and Its Interaction With Renal Function , 2012, Circulation. Heart failure.

[121]  P. Martens,et al.  How to tackle congestion in acute heart failure , 2018, The Korean journal of internal medicine.

[122]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[123]  F. Verbrugge,et al.  Renal sodium avidity in heart failure: from pathophysiology to treatment strategies , 2017, European heart journal.

[124]  Gerasimos Filippatos,et al.  Pathophysiologic targets in the early phase of acute heart failure syndromes. , 2005, The American journal of cardiology.

[125]  P. Martens,et al.  Current Approach to Decongestive Therapy in Acute Heart Failure , 2015, Current Heart Failure Reports.

[126]  S. Russell,et al.  Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. , 2018, JACC. Heart failure.

[127]  Paaladinesh Thavendiranathan,et al.  Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters. , 2014, The American journal of cardiology.

[128]  H. Krum,et al.  Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial , 2017, Journal of cachexia, sarcopenia and muscle.

[129]  G. Navis,et al.  Diuretic response in acute heart failure—pathophysiology, evaluation, and therapy , 2015, Nature Reviews Cardiology.

[130]  C. Parikh,et al.  Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. , 2013, Journal of the American College of Cardiology.

[131]  M. Chen,et al.  Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure. , 2017, Journal of the American Society of Nephrology : JASN.

[132]  S. Nagueh Non‐invasive assessment of left ventricular filling pressure , 2018, European journal of heart failure.

[133]  Akshay S. Desai,et al.  Are Serial BNP Measurements Useful in Heart Failure Management?: Serial Natriuretic Peptide Measurements Are Not Useful in Heart Failure Management The Art of Medicine Remains Long , 2013, Circulation.

[134]  R. Myerburg,et al.  Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. , 1991, The American journal of medicine.

[135]  James D. Thomas,et al.  Tissue Doppler Imaging in the Estimation of Intracardiac Filling Pressure in Decompensated Patients With Advanced Systolic Heart Failure , 2009, Circulation.

[136]  M. Vaduganathan,et al.  Hemoconcentration-guided diuresis in heart failure. , 2014, American Journal of Medicine.

[137]  J. Ferreira,et al.  Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. , 2014, European journal of internal medicine.

[138]  Sanjiv J. Shah,et al.  The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors , 2017, European journal of heart failure.

[139]  Monica R. Shah,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .

[140]  G. Filippatos,et al.  An introduction to acute heart failure syndromes: definition and classification , 2007, Heart Failure Reviews.

[141]  J. Cleland,et al.  The effects of short‐term omission of daily medication on the pathophysiology of heart failure , 2017, European journal of heart failure.

[142]  M. Böhm,et al.  A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptoms , 2015, Heart Failure Reviews.

[143]  J. Concato,et al.  Patterns of Weight Change Preceding Hospitalization for Heart Failure , 2007, Circulation.

[144]  N. Bayley,et al.  Failure , 1890, The Hospital.

[145]  W. Miller Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed. , 2016, Circulation. Heart failure.

[146]  G. Fonarow,et al.  Differential prognostic effect of systolic blood pressure on mortality according to left‐ventricular function in patients with acute heart failure , 2010, European journal of heart failure.

[147]  K. Anstrom,et al.  Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. , 2016, Journal of cardiac failure.

[148]  K. Anstrom,et al.  Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights from DOSE-AHF and CARRESS-HF , 2015 .

[149]  R. Guthrie Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.

[150]  R. Roberts,et al.  Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.

[151]  E. Colín-Ramírez,et al.  Salt in the diet in patients with heart failure: what to recommend , 2016, Current opinion in cardiology.

[152]  G. Navis,et al.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.